Xia P, Zheng Y, Dong L, Tian C
Authors not listed · 2021
Study shows 50% improvement in nasopharyngeal cancer outcomes with additional treatment in region most exposed to cell phone radiation.
Plain English Summary
This study examined whether adding a low-dose chemotherapy drug (capecitabine) after standard radiation treatment could prevent cancer recurrence in 406 patients with advanced nasopharyngeal cancer. After 3 years, patients receiving the additional drug had significantly better survival rates (85.3% vs 75.7%) with manageable side effects. The results suggest this approach could become a new standard treatment for this aggressive cancer.
Why This Matters
While this study focuses on cancer treatment rather than EMF exposure, it's worth noting that nasopharyngeal carcinoma occurs in the same anatomical region where cell phone radiation is most concentrated during calls. The nasopharynx sits directly behind the nose and receives the highest radiation dose when you hold a phone to your ear. Some research has suggested potential links between heavy cell phone use and this specific type of cancer, though the evidence remains limited. What's particularly relevant is that this study demonstrates how even small interventions can significantly impact survival rates in cancers affecting areas of high EMF exposure. The 50% reduction in treatment failure shows how critical it is to address all potential risk factors for cancers in EMF-sensitive regions. While we can't prevent all cancers, we can certainly reduce our unnecessary radiation exposure by using speakerphone, texting instead of calling, and keeping devices away from our heads during sleep.
Exposure Information
Specific exposure levels were not quantified in this study.
Show BibTeX
@article{xia_p_zheng_y_dong_l_tian_c_ce4596,
author = {Unknown},
title = {Xia P, Zheng Y, Dong L, Tian C},
year = {2021},
doi = {10.1016/S0140-6736(21)01123-5},
}